y 27632 has been researched along with Retinal Neovascularization in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Cui, Y; Guo, X; Huang, Q; Huang, X; Li, B; Wang, W; Weng, J; Zhang, S | 1 |
| Fang, X; Ikuno, Y; Ueno, M; Yamashita, T | 1 |
2 other study(ies) available for y 27632 and Retinal Neovascularization
| Article | Year |
|---|---|
Advanced glycation end products induce immature angiogenesis in in vivo and ex vivo mouse models.
Topics: Amides; Animals; Aorta; Capillary Permeability; Glycation End Products, Advanced; Mice; Mice, Knockout; Microfilament Proteins; Neovascularization, Pathologic; Phosphorylation; Pyridines; Receptor for Advanced Glycation End Products; Retina; Retinal Neovascularization; Signal Transduction | 2020 |
RhoA activation and effect of Rho-kinase inhibitor in the development of retinal neovascularization in a mouse model of oxygen-induced retinopathy.
Topics: Amides; Animals; Animals, Newborn; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Intravitreal Injections; Mice; Mice, Inbred C57BL; Oxygen; Pyridines; Retina; Retinal Neovascularization; rho GTP-Binding Proteins; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Treatment Outcome | 2011 |